- Research works
- 6 fractional, all time
- Citations
- 57 10.1 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 6% world 28%
Not ranked overall: Qlucore (Sweden) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which research topics does Qlucore (Sweden) publish most on?
By volume in 2022–2025: Acute Lymphoblastic Leukemia research, Chronic Myeloid Leukemia Treatments and RNA modifications and cancer.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 0 works
- 2 Chronic Myeloid Leukemia Treatments Hematology 0 works
- 3 RNA modifications and cancer Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Qlucore (Sweden)'s research output changed?
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Lund
- Lund University
- Skåne University Hospital
- MAX IV Laboratory
- European Spallation Source
- Lund Science (Sweden)
- Informa (Sweden)
- Swedish Institute for Health Economics
- Ideon Science Park
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.